These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 29240457)

  • 1. Urinary peptidomics in kidney disease and drug research.
    Krochmal M; Schanstra JP; Mischak H
    Expert Opin Drug Discov; 2018 Mar; 13(3):259-268. PubMed ID: 29240457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of urinary peptidomics in kidney disease research.
    Klein J; Bascands JL; Mischak H; Schanstra JP
    Kidney Int; 2016 Mar; 89(3):539-45. PubMed ID: 26880450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary Peptidomic Biomarkers in Kidney Diseases.
    Sirolli V; Pieroni L; Di Liberato L; Urbani A; Bonomini M
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31877774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization for Peptide Sample Preparation for Urine Peptidomics.
    Sigdel TK; Nicora CD; Qian WJ; Sarwal MM
    Methods Mol Biol; 2018; 1788():63-72. PubMed ID: 29623538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human tear proteomics and peptidomics in ophthalmology: Toward the translation of proteomic biomarkers into clinical practice.
    Azkargorta M; Soria J; Acera A; Iloro I; Elortza F
    J Proteomics; 2017 Jan; 150():359-367. PubMed ID: 27184738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Origins, Technological Development, and Applications of Peptidomics.
    Schrader M
    Methods Mol Biol; 2018; 1719():3-39. PubMed ID: 29476501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Origins, Technological Advancement, and Applications of Peptidomics.
    Schrader M
    Methods Mol Biol; 2024; 2758():3-47. PubMed ID: 38549006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical application of urinary proteomics/peptidomics.
    Albalat A; Mischak H; Mullen W
    Expert Rev Proteomics; 2011 Oct; 8(5):615-29. PubMed ID: 21999832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of Urine Peptides in Assessing Kidney and Cardiovascular Disease.
    Latosinska A; Siwy J; Faguer S; Beige J; Mischak H; Schanstra JP
    Proteomics Clin Appl; 2021 Jan; 15(1):e2000027. PubMed ID: 32710812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Peptidome Comes of Age: Mass Spectrometry-Based Characterization of the Circulating Cancer Peptidome.
    Greening DW; Kapp EA; Simpson RJ
    Enzymes; 2017; 42():27-64. PubMed ID: 29054270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptidomics coming of age: a review of contributions from a bioinformatics angle.
    Menschaert G; Vandekerckhove TT; Baggerman G; Schoofs L; Luyten W; Van Criekinge W
    J Proteome Res; 2010 May; 9(5):2051-61. PubMed ID: 20377245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The challenges of peptidomics in complementing proteomics in a clinical context.
    Maes E; Oeyen E; Boonen K; Schildermans K; Mertens I; Pauwels P; Valkenborg D; Baggerman G
    Mass Spectrom Rev; 2019 May; 38(3):253-264. PubMed ID: 30372792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Urinary peptidomics].
    Okumura N; Sudo K; Takao T
    Nihon Jinzo Gakkai Shi; 2010; 52(4):485-8. PubMed ID: 20560468
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of Urine and Plasma Peptidome Indicates Selectivity in Renal Peptide Handling.
    Magalhães P; Pontillo C; Pejchinovski M; Siwy J; Krochmal M; Makridakis M; Carrick E; Klein J; Mullen W; Jankowski J; Vlahou A; Mischak H; Schanstra JP; Zürbig P; Pape L
    Proteomics Clin Appl; 2018 Sep; 12(5):e1700163. PubMed ID: 29611317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease.
    Good DM; Zürbig P; Argilés A; Bauer HW; Behrens G; Coon JJ; Dakna M; Decramer S; Delles C; Dominiczak AF; Ehrich JH; Eitner F; Fliser D; Frommberger M; Ganser A; Girolami MA; Golovko I; Gwinner W; Haubitz M; Herget-Rosenthal S; Jankowski J; Jahn H; Jerums G; Julian BA; Kellmann M; Kliem V; Kolch W; Krolewski AS; Luppi M; Massy Z; Melter M; Neusüss C; Novak J; Peter K; Rossing K; Rupprecht H; Schanstra JP; Schiffer E; Stolzenburg JU; Tarnow L; Theodorescu D; Thongboonkerd V; Vanholder R; Weissinger EM; Mischak H; Schmitt-Kopplin P
    Mol Cell Proteomics; 2010 Nov; 9(11):2424-37. PubMed ID: 20616184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptidomics of urine and other biofluids for cancer diagnostics.
    Bauça JM; Martínez-Morillo E; Diamandis EP
    Clin Chem; 2014 Aug; 60(8):1052-61. PubMed ID: 24212086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards characterization of the human urinary peptidome.
    Jürgens M; Appel A; Heine G; Neitz S; Menzel C; Tammen H; Zucht HD
    Comb Chem High Throughput Screen; 2005 Dec; 8(8):757-65. PubMed ID: 16464162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary proteomics based on capillary electrophoresis-coupled mass spectrometry in kidney disease: discovery and validation of biomarkers, and clinical application.
    Mischak H; Delles C; Klein J; Schanstra JP
    Adv Chronic Kidney Dis; 2010 Nov; 17(6):493-506. PubMed ID: 21044772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptidomics analysis of human blood specimens for biomarker discovery.
    Tammen H; Peck A; Budde P; Zucht HD
    Expert Rev Mol Diagn; 2007 Sep; 7(5):605-13. PubMed ID: 17892366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The emerging role of the peptidome in biomarker discovery and degradome profiling.
    Lai ZW; Petrera A; Schilling O
    Biol Chem; 2015 Mar; 396(3):185-92. PubMed ID: 25229414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.